AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 204 filers reported holding AMICUS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $455,000 | -5.2% | 49,241 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $480,000 | +21.5% | 49,241 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $395,000 | -6.4% | 49,241 | +45.5% | 0.01% | -11.1% |
| Q2 2019 | $422,000 | -8.3% | 33,841 | 0.0% | 0.01% | -10.0% |
| Q1 2019 | $460,000 | +42.0% | 33,841 | 0.0% | 0.01% | +25.0% |
| Q4 2018 | $324,000 | -54.2% | 33,841 | -42.1% | 0.01% | -20.0% |
| Q3 2018 | $708,000 | +54.9% | 58,482 | +100.0% | 0.01% | 0.0% |
| Q2 2018 | $457,000 | +18.4% | 29,241 | +14.0% | 0.01% | +11.1% |
| Q1 2018 | $386,000 | +76.3% | 25,641 | +68.2% | 0.01% | +200.0% |
| Q4 2017 | $219,000 | – | 15,241 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |